Analyst Ratings for Moderna (MRNA) [Sells]

MRNA Rating Summary

MRNA Price Target Summary

* Over Last 12-Mos
  |   Expand Research on MRNA
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $162.46 (-25.8%) * Over Last 12-Mos
Rating Score: 5 / 10   Percentile Rank: 50%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/1/2021 BofA Securities Geoff Meacham Downgrade Underperform
(Neutral)
N/A
(N/A)
173.16
(218.85)
26.39% Details
9/8/2020 SVB Leerink
» Updated 5/6/2021
Mani Foroohar Downgrade Underperform
(Market Perform)
83.00
(79.00)
62.60
(218.85)
249.6% Details
Like MRNA Ratings? Also take a look at PFE, AZN, JNJ, BNTX

MRNA Ratings News